Literature DB >> 20624918

Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.

Leo Studach1, Wen-Horng Wang, Gregory Weber, Jiabin Tang, Ronald L Hullinger, Raphael Malbrue, Xiaoqi Liu, Ourania Andrisani.   

Abstract

Hepatitis B virus X protein (pX), implicated in hepatocarcinogenesis, induces DNA damage because of re-replication and allows propagation of damaged DNA, resulting in partial polyploidy and oncogenic transformation. The mechanism by which pX allows cells with DNA damage to continue proliferating is unknown. Herein, we show pX activates Polo-like kinase 1 (Plk1) in the G(2) phase, thereby attenuating the DNA damage checkpoint. Specifically, in the G(2) phase of pX-expressing cells, the checkpoint kinase Chk1 was inactive despite DNA damage, and protein levels of claspin, an adaptor of ataxia telangiectasia-mutated and Rad3-related protein-mediated Chk1 phosphorylation, were reduced. Pharmacologic inhibition or knockdown of Plk1 restored claspin protein levels, Chk1 activation, and p53 stabilization. Also, protein levels of DNA repair protein Mre11 were decreased in the G(2) phase of pX-expressing cells but not with Plk1 knockdown. Interestingly, in pX-expressing cells, Mre11 co-immunoprecipitated with transfected Plk1 Polo-box domain, and inhibition of Plk1 increased Mre11 stability in cycloheximide-treated cells. These results suggest that pX-activated Plk1 by down-regulating Mre11 attenuates DNA repair. Importantly, concurrent inhibition of Plk1, p53, and Mre11 increased the number of pX-expressing cells with DNA damage entering mitosis, relative to Plk1 inhibition alone. By contrast, inhibition or knockdown of Plk1 reduced pX-induced polyploidy while increasing apoptosis. We conclude Plk1, activated by pX, allows propagation of DNA damage by concurrently attenuating the DNA damage checkpoint and DNA repair, resulting in polyploidy. We propose this novel Plk1 mechanism initiates pX-mediated hepatocyte transformation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624918      PMCID: PMC2943266          DOI: 10.1074/jbc.M109.093963

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Cdc2-mediated phosphorylation of CLIP-170 is essential for its inhibition of centrosome reduplication.

Authors:  Xiaoming Yang; Hongchang Li; X Shawn Liu; Anping Deng; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2009-08-17       Impact factor: 5.157

3.  Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines.

Authors:  C Tarn; M L Bilodeau; R L Hullinger; O M Andrisani
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

4.  Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery.

Authors:  X Shawn Liu; Hongchang Li; Bing Song; Xiaoqi Liu
Journal:  EMBO Rep       Date:  2010-06-25       Impact factor: 8.807

Review 5.  Getting in and out of mitosis with Polo-like kinase-1.

Authors:  Marcel A T M van Vugt; René H Medema
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

6.  Polo-like kinase-1 is a target of the DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; L Arnaud; G Rijksen; E A Nigg; R H Medema
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

Review 7.  The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review).

Authors:  O M Andrisani; S Barnabas
Journal:  Int J Oncol       Date:  1999-08       Impact factor: 5.650

Review 8.  Polo-like kinases and oncogenesis.

Authors:  Frank Eckerdt; Juping Yuan; Klaus Strebhardt
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

Review 9.  Polo-like kinases (Plks) and cancer.

Authors:  Noriyuki Takai; Ryoji Hamanaka; Jun Yoshimatsu; Isao Miyakawa
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

10.  Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression.

Authors:  Wen-Horng Wang; Gérald Grégori; Ronald L Hullinger; Ourania M Andrisani
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more
  22 in total

1.  Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.

Authors:  Leo L Studach; Stephan Menne; Stefano Cairo; Marie Annick Buendia; Ronald L Hullinger; Lydie Lefrançois; Philippe Merle; Ourania M Andrisani
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

2.  Chemical visualization of phosphoproteomes on membrane.

Authors:  Anton Iliuk; X Shawn Liu; Liang Xue; Xiaoqi Liu; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2012-05-16       Impact factor: 5.911

Review 3.  Hepatocellular carcinoma.

Authors:  Marie-Annick Buendia; Christine Neuveut
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

4.  Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.

Authors:  James Ahodantin; Myriam Bou-Nader; Corinne Cordier; Jérôme Mégret; Patrick Soussan; Chantal Desdouets; Dina Kremsdorf
Journal:  Oncogene       Date:  2018-12-11       Impact factor: 9.867

5.  Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.

Authors:  Ahmed Diab; Adrien Foca; Floriane Fusil; Thomas Lahlali; Pascal Jalaguier; Fouzia Amirache; Lia N'Guyen; Nathalie Isorce; François-Loïc Cosset; Fabien Zoulim; Ourania Andrisani; David Durantel
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

6.  Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.

Authors:  Wen-Horng Wang; Leo L Studach; Ourania M Andrisani
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

7.  PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis.

Authors:  Hao Zhang; Ahmed Diab; Huitao Fan; Saravana Kumar Kailasam Mani; Ronald Hullinger; Philippe Merle; Ourania Andrisani
Journal:  Cancer Res       Date:  2015-04-08       Impact factor: 12.701

8.  At a crossroads: human DNA tumor viruses and the host DNA damage response.

Authors:  Pavel A Nikitin; Micah A Luftig
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

9.  Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

Authors:  Shirine Benhenda; Aurélie Ducroux; Lise Rivière; Bijan Sobhian; Michael D Ward; Sarah Dion; Olivier Hantz; Ulrike Protzer; Marie-Louise Michel; Monsef Benkirane; Oliver J Semmes; Marie-Annick Buendia; Christine Neuveut
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 10.  Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.

Authors:  Li Ma; Mei-Sze Chua; Ourania Andrisani; Samuel So
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.